试点全州急诊科带回家纳洛酮项目:改善阿片类药物过量风险患者的照护质量
该研究试点全州急诊科带回家纳洛酮项目,招募9家有药学、护理和医师骨干的医院急诊科,进行调研和培训,开发、分发并追踪带回家纳洛酮急救包,在COVID大流行前召开两次过量预防峰会,并安排两次面向急诊医师和高级实践提供者的X-waiver培训课程(线上线下结合)。结果第一阶段向有阿片类药物过量风险的急诊患者发放872个纳洛酮急救包,超过140名提供者在急性照护环境中接受了OUD药物治疗培训。结论认为该项目在不同既往OUD资源与能力成熟度的医院间均可行,未来工作将扩大并评估有效性。
要点
- 9家医院急诊科参与试点,均有药学、护理和医师骨干,接受调研和培训。
- 第一阶段向有阿片类药物过量风险的急诊患者发放872个纳洛酮急救包。
- 超过140名提供者在急性照护环境中接受了OUD药物治疗培训。
- COVID大流行前召开两次过量预防峰会,并安排两次X-waiver培训课程(线下和虚拟)。
- 作者认为全州急诊科带回家纳洛酮项目在不同既往OUD资源与能力成熟度的医院间可行。
适用人群与场景
- 有阿片类药物过量风险的急诊科患者,包括非致命性阿片类药物过量患者和有风险药物使用患者。
- 参与项目的9家医院急诊科,均设有药学、护理和医师骨干。
处置流程与药物剂量
- 开发、分发并追踪带回家纳洛酮急救包,第一阶段向有阿片类药物过量风险的急诊患者发放872个。
- 在COVID大流行前召开两次过量预防峰会。
- 安排两次X-waiver培训课程,面向急诊医师和高级实践提供者,采用线下和虚拟形式,超过140名提供者接受急性照护环境中OUD药物治疗培训。
研究设计与关键结果
- 项目为试点全州急诊科带回家纳洛酮项目,招募9家医院急诊科,进行调研和培训。
- 第一阶段向有阿片类药物过量风险的急诊患者发放872个纳洛酮急救包。
- 超过140名提供者在急性照护环境中接受了OUD药物治疗培训。
- 作者结论认为该项目在不同既往OUD资源与能力成熟度的医院间可行,未来工作将扩大并评估有效性。
证据类型、等级与局限
- 证据类型:试点项目描述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为全州急诊科带回家纳洛酮项目在不同既往OUD资源与能力成熟度的医院间可行,未来工作将扩大并评估有效性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Emergency department (ED) patients with nonfatal opioid overdose are at high risk for subsequent fatal overdose, yet ED programs aimed at reducing harm from opioid use remain underdeveloped.
OBJECTIVES: The objective was to pilot a statewide ED take-home naloxone program and improve the care of patients with opioid use disorder (OUD) and risky drug use through training and interprofessional network building.
METHODS: Nine hospital EDs with pharmacy, nurse, and physician champions were recruited, surveyed, and trained. Take-home naloxone rescue kits were developed, disseminated, and tracked. Two overdose prevention summits were convened prior to the COVID pandemic, and two X-waiver training courses aimed at emergency physicians and advanced practice providers were arranged, both in person and virtual.
RESULTS: A total of 872 naloxone rescue kits were distributed to ED patients at risk of opioid overdose during the first phase of this project, and more than 140 providers were trained in the use of medications for OUD in acute care settings.
CONCLUSIONS: A statewide ED take-home naloxone program was shown to be feasible across a range of different hospitals with varying maturity in preexisting OUD resources and capabilities. Future work will be aimed at both expanding and measuring the effectiveness of this work.
参考来源
- Dora-Laskey A, Kellenberg J, Dahlem CH, et al. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose. Acad Emerg Med. 2022. PMID: 34962682. doi:10.1111/acem.14435
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。